Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases
No Preview Available
Citations
Altmetric:
Altmetric::
Associated Records
Authors
File Licence
Editors
Date
2021-04-01
Source Title
Seminars in Cell and Developmental Biology
Journal Title
Journal ISSN
Volume Title
Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
Melbourne Authors
Affiliation
Florey Department of Neuroscience and Mental Health
Document Type
Journal Article
Subject Code
Citation
Bouscary, A., Quessada, C., René, F., Spedding, M., Turner, B. J., Henriques, A., Ngo, S. T. & Loeffler, J. P. (2021). Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Seminars in Cell and Developmental Biology, 112, pp.82-91. https://doi.org/10.1016/j.semcdb.2020.10.008.
Access Status
Access this item via the Open Access location
Access URL
Open Access URL
Open Access at PMC
Linked Resource URL
NHMRC Grant Code
ARC Grant Code
Description
Abstract
Sphingolipids are complex lipids. They play a structural role in neurons, but are also involved in regulating cellular communication, and neuronal differentiation and maturation. There is increasing evidence to suggest that dysregulated metabolism of sphingolipids is linked to neurodegenerative processes in amyotrophic lateral sclerosis (ALS), Parkinson's disease and Gaucher's disease. In this review, we provide an overview of the role of sphingolipids in the development and maintenance of the nervous system. We describe the implications of altered metabolism of sphingolipids in the pathophysiology of certain neurodegenerative diseases, with a primary focus on ALS. Finally, we provide an update of potential treatments that could be used to target the metabolism of sphingolipids in neurodegenerative diseases.